Category

Term

Count

Count %

P-Value

KEGG_PATHWAY

Neuroactive ligand-receptor interaction

18

27.7

7.1E−11

KEGG_PATHWAY

Pathways in cancer

18

27.7

1.6E−08

KEGG_PATHWAY

Calcium signaling pathway

13

20

2.6E−08

KEGG_PATHWAY

Hepatitis B

11

16.9

3.3E−07

KEGG_PATHWAY

Cholinergic synapse

10

15.4

3.4E−07

KEGG_PATHWAY

Colorectal cancer

8

12.3

8.1E−07

KEGG_PATHWAY

Morphine addiction

9

13.8

8.8E−07

KEGG_PATHWAY

Thyroid hormone signaling pathway

9

13.8

0.0000052

KEGG_PATHWAY

Estrogen signaling pathway

8

12.3

0.000019

KEGG_PATHWAY

Retrograde endocannabinoid signaling

8

12.3

0.000022

KEGG_PATHWAY

Serotonergic synapse

8

12.3

0.00004

KEGG_PATHWAY

Small cell lung cancer

7

10.8

0.000079

KEGG_PATHWAY

Progesterone-mediated oocyte maturation

7

10.8

0.000091

KEGG_PATHWAY

Prostate cancer

7

10.8

0.000097

KEGG_PATHWAY

PI3K-Akt signaling pathway

12

18.5

0.00014

KEGG_PATHWAY

Adrenergic signaling in cardiomyocytes

8

12.3

0.00016

KEGG_PATHWAY

VEGF signaling pathway

6

9.2

0.00016

KEGG_PATHWAY

Apoptosis

6

9.2

0.00017

KEGG_PATHWAY

Amphetamine addiction

6

9.2

0.00023

KEGG_PATHWAY

p53 signaling pathway

6

9.2

0.00025

KEGG_PATHWAY

Non-alcoholic fatty liver disease (NAFLD)

8

12.3

0.00028

KEGG_PATHWAY

Viral carcinogenesis

9

13.8

0.00033

KEGG_PATHWAY

Toxoplasmosis

7

10.8

0.00033

KEGG_PATHWAY

Nicotine addiction

5

7.7

0.00035

KEGG_PATHWAY

Tuberculosis

8

12.3

0.00073

KEGG_PATHWAY

GABAergic synapse

6

9.2

0.00076

KEGG_PATHWAY

Salivary secretion

6

9.2

0.0008

KEGG_PATHWAY

Amyotrophic lateral sclerosis (ALS)

5

7.7

0.00084